266.83 USD
↘ 0.78 (0.29%)PRE MARKET (AS OF 06:18 AM EDT)
Johnson & Johnson (JNJ) trades at $266.83 per share. The technical outlook is "Strong Buy" and the fundamental picture shows "Neutral". This is driven by a robust Altman Z-Score and a bullish Golden Cross on the moving averages. On the valuation front, JNJ trades at elevated multiples relative to its peers, earning a "Richly Valued" assessment.
Technical & fundamental data as of Oct 22, 2026.
Open?$267.22
High?$267.22
Low?$265.58
Prev. Close?$267.61
Volume?7.2K
Avg. Volume?7.4M
VWAP?$266.20
Rel. Volume?0.00x
Bid / Ask
Bid?$265.63 × 100
Ask?$266.51 × 100
Spread?$0.88
Midpoint?$266.07
Valuation & Ratios
Market Cap?644.2B
Shares Out?2.4B
Float?2.4B
Float %?100.0%
P/E Ratio?40.03
P/B Ratio?7.90
EPS?$6.69
Dividend?1.97%
Ex-Dividend?2026-11-24
News
Profile
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
Themes
Employees
140.8K
Market Cap
644.2B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
1944-09-25
Address
ONE JOHNSON & JOHNSON PLZ
NEW BRUNSWICK, NJ 08933
Phone: 732-524-2455
NEW BRUNSWICK, NJ 08933
Phone: 732-524-2455
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?▲ Bullish(+3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?23
Z-Score?99
Momentum?48
Short Sent.?78
Piotroski F-Score?3/9Weak
Altman Z-Score?5.45Safe
Confidence?60%Moderate
Short InterestModerate
Short % of Float?0.92%Low
Short Interest?22.1M
Days to Cover?3.3
Free Float2.4B
Avg Daily Volume6.8M
Settlement Date2026-09-30
Financial Health
Current Ratio?1.02Adequate
Quick Ratio?0.74Weak
Cash Ratio?0.30Low
Debt/Equity?0.55Moderate
ValuationRICHLY VALUEDvs 9 peers + S&P 500
Score50/100
P/E?40.0PRICEY▾
Peers63
S&P18
P/B?7.90FAIR▾
Peers63
S&P24
P/S?6.49FAIR▾
Peers50
S&P19
P/FCF?31.9FAIR▾
Peers38
S&P26
EV/EBITDA?20.3HIGH▾
Peers50
S&P25
EV/Sales?6.76HIGH▾
Peers50
S&P22
Returns & Efficiency
ROE?19.7%STRONG▾
Peers63
S&P65
ROA?8.2%STRONG▾
Peers75
S&P66
Cash Flow & Enterprise
FCF?$20.2B
Enterprise Value?$672.0B
Fundamentals ratios updated end of day